CoChat

Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study

Open access
Kim, Kyung-Soo, Hong, Sangmo, Han, Kyungdo, Park, Cheol-Young · 2024 · BMJ
Cited by 173

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Objective: To investigate the risk of non-alcoholic fatty liver disease (NAFLD) for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus (T2DM). Design: Nationwide population based study. Setting: Longitudinal cohort study in Korea. Participants: 7 796 763 participants in the National Health Screening Programme in 2009 were divided into three groups based on NAFLD status: no NAFLD (fatty liver index<30); grade 1 NAFLD (30≤fatty liver index<60); and grade 2 NAFLD (fatty liver index≥60). Median follow-up was 8.13 years. Main outcome measures: The primary outcome was incident cardiovascular disease (myocardial infarction, ischaemic stroke) or all cause death. Results: Of 7 796 763 participants, 6.49% (n=505 763) had T2DM. More patients with T2DM had grade 1 NAFLD (34.06%) and grade 2 NAFLD (26.73%) than those without T2DM (grade 1 NAFLD: 21.20%; grade 2 NAFLD: 10.02%). The incidence rate (per 1000 person years) of cardiovascular disease and all cause death increased in the order of no NAFLD, grade 1 NAFLD, and grade 2 NAFLD, and the incidence rates in patients with T2DM were higher than those in patients without T2DM. The five year absolute risk for cardiovascular disease and all cause death increased in the order of no NAFLD, grade 1 NAFLD, and grade 2 NAFLD in patients without and with T2DM (no NAFLD, without T2DM: 1.03, 95% confidence interval 1.02 to 1.04, and 1.25, 1.24 to 1.26, respectively; grade 1 NAFLD, without T2DM: 1.23, 1.22 to 1.25, and 1.50, 1.48 to 1.51, respectively; grade 2 NAFLD, without T2DM: 1.42, 1.40 to 1.45, and 2.09, 2.06 to 2.12, respectively; no NAFLD, with T2DM: 3.34, 3.27 to 3.41, and 3.68, 3.61 to 3.74, respectively; grade 1 NAFLD, with T2DM: 3.94, 3.87 to 4.02, and 4.25, 4.18 to 4.33, respectively; grade 2 NAFLD, with T2DM: 4.66, 4.54 to 4.78, and 5.91, 5.78 to 6.05, respectively). Patients with T2DM and without NAFLD had a higher five year absolute risk for cardiovascular disease and all cause death than those without T2DM and with grade 2 NAFLD. Risk differences for cardiovascular disease and all cause death between no NAFLD and grade 1 or grade 2 NAFLD were higher in patients with T2DM than in those without T2DM. Conclusions: NAFLD in patients with T2DM seems to be associated with a higher risk of cardiovascular disease and all cause death, even in patients with mild NAFLD. Risk differences for cardiovascular disease and all cause death between the no NAFLD group and the grade 1 or grade 2 NAFLD groups were higher in patients with T2DM than in those without T2DM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj-2023-076388

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 32

  1. 10.1002/hep.28431 · DOI · Paper page
  2. 10.4093/dmj.2022.0444 · DOI
  3. 10.1002/hep.26672 · DOI · Paper page
  4. 10.1002/oby.23438 · DOI
  5. 10.4093/dmj.2021.0327 · DOI
  6. 10.1016/j.metabol.2021.154770 · DOI · Paper page
  7. 10.1016/S2213-8587(22)00003-1 · DOI · Paper page
  8. 10.1007/s11892-021-01383-7 · DOI · Paper page
  9. 10.1016/j.jhep.2008.06.018 · DOI · Paper page
  10. 10.4093/dmj.2022.0106 · DOI · Paper page
  11. 10.4093/dmj.2020.0010 · DOI
  12. 10.2337/dc07-0349 · DOI · Paper page
  13. 10.2337/diabetes.54.12.3541 · DOI · Paper page
  14. 10.2337/dc17-1590 · DOI · Paper page
  15. 10.1186/1471-230X-6-33 · DOI · Paper page
  16. 10.4093/dmj.2019.0034 · DOI
  17. 10.3803/EnM.2022.102 · DOI
  18. 10.1002/hep4.1155 · DOI · Paper page
  19. 10.1016/j.jhep.2016.05.013 · DOI · Paper page
  20. 10.1016/S1665-2681(19)31850-2 · DOI
  21. 10.1530/EJE-14-0112 · DOI · Paper page
  22. 10.1097/MD.0000000000001682 · DOI · Paper page
  23. 10.1371/journal.pone.0107584 · DOI · Paper page
  24. 10.3390/diagnostics11122233 · DOI
  25. 10.1186/s12933-022-01483-y · DOI
  26. 10.1111/apt.16706 · DOI
  27. 10.1111/dom.14597 · DOI
  28. 10.1016/j.atherosclerosis.2019.01.029 · DOI
  29. 10.1007/s00125-019-05024-3 · DOI · Paper page
  30. 10.1016/S0735-1097(03)00088-3 · DOI · Paper page
  31. 10.1007/s00125-016-3952-1 · DOI · Paper page
  32. 10.1111/j.1478-3231.2011.02580.x · DOI

Cited by

See all 173

Metadata

Authors
Kim, K.-S., Hong, S., Han, K., & Park, C.-Y.
Venue
BMJ
Publisher
BMJ
Published
2024-02-13
Volume
384
Pages
e076388
ISSN
1756-1833 (ISSN-L)
OpenAlex
W4391799523
Cited by
173
References
9
FWCI
45.23
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study. https://app.cochat.ai/papers/10.1136/bmj-2023-076388
The paper
Kim, K.-S., Hong, S., Han, K., & Park, C.-Y. (2024). Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study. BMJ. https://doi.org/10.1136/bmj-2023-076388

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.